Quipt Home Medical (QIPT)
(Delayed Data from NSDQ)
$3.31 USD
-0.06 (-1.78%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $3.31 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth NA Momentum NA VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QIPT 3.31 -0.06(-1.78%)
Will QIPT be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for QIPT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QIPT
Prestige Consumer Healthcare (PBH) Misses Q4 Earnings and Revenue Estimates
Phibro (PAHC) Moves 31.8% Higher: Will This Strength Last?
QIPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Quipt Home Medical Corp. (QIPT) Reports Q1 Loss, Tops Revenue Estimates
Earnings Preview: Agios Pharmaceuticals (AGIO) Q4 Earnings Expected to Decline
Quipt Home Medical Corp. (QIPT) Expected to Beat Earnings Estimates: Should You Buy?
Other News for QIPT
Quipt Home Medical Launches New Incentive Plan
Quipt Home Medical management to meet virtually with Roth MKM
Quipt Home Medical management to meet virtually with Roth MKM
Quipt Home Medical price target lowered by $1 at Benchmark, here's why
Quipt Home Medical price target lowered by C$1 at Stifel